SNDL Inc
F:VY4

Watchlist Manager
SNDL Inc Logo
SNDL Inc
F:VY4
Watchlist
Price: 1.206 EUR 0.5% Market Closed
Market Cap: 318.7m EUR

Relative Value

The Relative Value of one VY4 stock under the Base Case scenario is hidden EUR. Compared to the current market price of 1.206 EUR, SNDL Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VY4 Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
92
vs Industry
79
Median 3Y
0.8
Median 5Y
1.1
Industry
2.5
Forward
0.5
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-4.8
Industry
21.6
Forward
-73.7
vs History
22
vs Industry
30
Median 3Y
-8.1
Median 5Y
-9.8
Industry
16.7
vs History
12
vs Industry
Median 3Y
-7.3
Median 5Y
-7.7
Industry
24
vs History
79
vs Industry
75
Median 3Y
0.5
Median 5Y
0.6
Industry
2.2
vs History
95
vs Industry
86
Median 3Y
0.6
Median 5Y
0.9
Industry
2.7
Forward
0.4
vs History
95
vs Industry
72
Median 3Y
2.6
Median 5Y
3.8
Industry
5.3
vs History
26
vs Industry
12
Median 3Y
10
Median 5Y
-13.7
Industry
12.9
Forward
21.7
vs History
vs Industry
Median 3Y
-12.4
Median 5Y
-12.7
Industry
16.3
Forward
-116.4
vs History
22
vs Industry
39
Median 3Y
-6.4
Median 5Y
-5.9
Industry
15.2
vs History
22
vs Industry
29
Median 3Y
-6.2
Median 5Y
-5.8
Industry
17.7
vs History
76
vs Industry
78
Median 3Y
0.4
Median 5Y
0.5
Industry
1.9

Multiples Across Competitors

VY4 Competitors Multiples
SNDL Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
SNDL Inc
F:VY4
310.3m EUR 0.5 -4.6 12.7 -15
US
Eli Lilly and Co
NYSE:LLY
754.8B USD 15.4 68 36.5 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
376.3B USD 4.2 17.3 12.6 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 6.5 18.8 13 14.9
CH
Roche Holding AG
SIX:ROG
204.5B CHF 3.4 24.7 9.3 10.9
CH
Novartis AG
SIX:NOVN
188.6B CHF 4.4 18.4 10.8 14.5
UK
AstraZeneca PLC
LSE:AZN
165.3B GBP 4.1 28.7 131 197.5
US
Merck & Co Inc
NYSE:MRK
210.7B USD 3.3 12.1 9 10.9
IE
Endo International PLC
LSE:0Y5F
184.8B USD 79.7 -63.2 294 737.3
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 18.4 7.8 11
P/S Multiple
Revenue Growth P/S to Growth
CA
SNDL Inc
F:VY4
Average P/S: 63.8
0.5
5%
0.1
US
Eli Lilly and Co
NYSE:LLY
15.4
23%
0.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
578.3
9%
64.3
US
Johnson & Johnson
NYSE:JNJ
4.2
4%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
6.5
15%
0.4
CH
Roche Holding AG
SIX:ROG
3.4
4%
0.8
CH
Novartis AG
SIX:NOVN
4.4
4%
1.1
UK
AstraZeneca PLC
LSE:AZN
4.1
7%
0.6
US
Merck & Co Inc
NYSE:MRK
3.3
4%
0.8
IE
E
Endo International PLC
LSE:0Y5F
79.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
2.3
-1%
N/A
P/E Multiple
Earnings Growth PEG
CA
SNDL Inc
F:VY4
Average P/E: 25.8
Negative Multiple: -4.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
68
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.3
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
18.8
18%
1
CH
Roche Holding AG
SIX:ROG
24.7
32%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
28.7
36%
0.8
US
Merck & Co Inc
NYSE:MRK
12.1
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -63.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
18.4
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
SNDL Inc
F:VY4
Average EV/EBITDA: 398.5
12.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.5
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.6
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
13
13%
1
CH
Roche Holding AG
SIX:ROG
9.3
5%
1.9
CH
Novartis AG
SIX:NOVN
10.8
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
131
10%
13.1
US
Merck & Co Inc
NYSE:MRK
9
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
294
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.8
2%
3.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
SNDL Inc
F:VY4
Average EV/EBIT: 1 875.6
Negative Multiple: -15
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.9
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.5
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.9
14%
1.1
CH
Roche Holding AG
SIX:ROG
10.9
6%
1.8
CH
Novartis AG
SIX:NOVN
14.5
10%
1.5
UK
AstraZeneca PLC
LSE:AZN
197.5
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.9
11%
1
IE
E
Endo International PLC
LSE:0Y5F
737.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
11
10%
1.1